141 related articles for article (PubMed ID: 35560269)
1. Socio-economic burden of disease: Survivorship costs for bladder cancer.
Michaeli JC; Boch T; Albers S; Michaeli T; Michaeli DT
J Cancer Policy; 2022 Jun; 32():100326. PubMed ID: 35560269
[TBL] [Abstract][Full Text] [Related]
2. Socio-economic burden of disease: Survivorship costs for renal cell carcinoma.
Michaeli JC; Michaeli DT; Boch T; Albers S; Michaeli T
Eur J Cancer Care (Engl); 2022 May; 31(3):e13569. PubMed ID: 35293070
[TBL] [Abstract][Full Text] [Related]
3. Testicular cancer follow-up costs in Germany from 2000 to 2015.
Michaeli T; Michaeli J; Michaeli D
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2249-2258. PubMed ID: 33885951
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer follow-up costs in Germany from 2000 to 2015.
Michaeli T; Michaeli D
J Cancer Surviv; 2022 Feb; 16(1):86-94. PubMed ID: 33646503
[TBL] [Abstract][Full Text] [Related]
5. Economic Burden of Bladder Cancer Across the European Union.
Leal J; Luengo-Fernandez R; Sullivan R; Witjes JA
Eur Urol; 2016 Mar; 69(3):438-47. PubMed ID: 26508308
[TBL] [Abstract][Full Text] [Related]
6. The burden of bladder cancer care: direct and indirect costs.
Mossanen M; Gore JL
Curr Opin Urol; 2014 Sep; 24(5):487-91. PubMed ID: 24887047
[TBL] [Abstract][Full Text] [Related]
7. [Socio-economic aspects of neurogenic dysfunctions in urology].
Kasyan GR; Dreval RO; Krivoborodov GG; Gadzhieva ZK; Salyukov RV; Stroganov RV; Shipitsyn VV
Urologiia; 2020 Nov; (5):127-132. PubMed ID: 33185360
[TBL] [Abstract][Full Text] [Related]
8. The Economic Burden of Cancer in Canada from a Societal Perspective.
Garaszczuk R; Yong JHE; Sun Z; de Oliveira C
Curr Oncol; 2022 Apr; 29(4):2735-2748. PubMed ID: 35448197
[TBL] [Abstract][Full Text] [Related]
9. Socio-Economic Burden of Myasthenia Gravis: A Cost-of-Illness Study in Bulgaria.
Ignatova V; Kostadinov K; Vassileva E; Muradyan N; Stefanov G; Iskrov G; Stefanov R
Front Public Health; 2022; 10():822909. PubMed ID: 35309194
[TBL] [Abstract][Full Text] [Related]
10. Economic burden of major depressive disorder: a case study in Southern Iran.
Keshavarz K; Hedayati A; Rezaei M; Goudarzi Z; Moghimi E; Rezaee M; Lotfi F
BMC Psychiatry; 2022 Aug; 22(1):577. PubMed ID: 36042423
[TBL] [Abstract][Full Text] [Related]
11. The social and economic burden of stroke survivors in Italy: a prospective, incidence-based, multi-centre cost of illness study.
Fattore G; Torbica A; Susi A; Giovanni A; Benelli G; Gozzo M; Toso V
BMC Neurol; 2012 Nov; 12():137. PubMed ID: 23150894
[TBL] [Abstract][Full Text] [Related]
12. The Economic Burden of Breast Cancer Survivors in Korea: A Descriptive Study Using a 26-Month Micro-Costing Cohort Approach.
You CH; Kang S; Kwon YD
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2131-2137. PubMed ID: 31350976
[TBL] [Abstract][Full Text] [Related]
13. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update.
Babjuk M; Burger M; Compérat EM; Gontero P; Mostafid AH; Palou J; van Rhijn BWG; Rouprêt M; Shariat SF; Sylvester R; Zigeuner R; Capoun O; Cohen D; Escrig JLD; Hernández V; Peyronnet B; Seisen T; Soukup V
Eur Urol; 2019 Nov; 76(5):639-657. PubMed ID: 31443960
[TBL] [Abstract][Full Text] [Related]
14. The economics of bladder cancer: costs and considerations of caring for this disease.
Svatek RS; Hollenbeck BK; Holmäng S; Lee R; Kim SP; Stenzl A; Lotan Y
Eur Urol; 2014 Aug; 66(2):253-62. PubMed ID: 24472711
[TBL] [Abstract][Full Text] [Related]
15. The Direct and Indirect Costs of Breast Cancer in Poland: Estimates for 2017-2019.
Seweryn M; Banas T; Augustynska J; Lorenc O; Kopel J; Pluta E; Skora T
Int J Environ Res Public Health; 2022 Dec; 19(24):. PubMed ID: 36554267
[TBL] [Abstract][Full Text] [Related]
16. The economic burden of cancer in Korea in 2009.
Kim SY; Park JH; Kang KH; Hwang I; Yang HK; Won YJ; Seo HG; Lee D; Yoon SJ
Asian Pac J Cancer Prev; 2015; 16(3):1295-301. PubMed ID: 25735370
[TBL] [Abstract][Full Text] [Related]
17. Healthcare Costs Associated with an Adequate Intake of Sugars, Salt and Saturated Fat in Germany: A Health Econometrical Analysis.
Meier T; Senftleben K; Deumelandt P; Christen O; Riedel K; Langer M
PLoS One; 2015; 10(9):e0135990. PubMed ID: 26352606
[TBL] [Abstract][Full Text] [Related]
18. Systematic Review on Healthcare and Societal Costs of Tinnitus.
Trochidis I; Lugo A; Borroni E; Cederroth CR; Cima R; Kikidis D; Langguth B; Schlee W; Gallus S
Int J Environ Res Public Health; 2021 Jun; 18(13):. PubMed ID: 34206904
[TBL] [Abstract][Full Text] [Related]
19. EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.
Babjuk M; Böhle A; Burger M; Capoun O; Cohen D; Compérat EM; Hernández V; Kaasinen E; Palou J; Rouprêt M; van Rhijn BWG; Shariat SF; Soukup V; Sylvester RJ; Zigeuner R
Eur Urol; 2017 Mar; 71(3):447-461. PubMed ID: 27324428
[TBL] [Abstract][Full Text] [Related]
20. The national economic burden of rare disease in the United States in 2019.
Yang G; Cintina I; Pariser A; Oehrlein E; Sullivan J; Kennedy A
Orphanet J Rare Dis; 2022 Apr; 17(1):163. PubMed ID: 35414039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
